Skip to content

Effect of EMLA cream on pain during insertion of IUD

A comparison of EMLA cream and placebo on pain during IUD insertion in women referred to health centers of Imam Hussein.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201209015698N4
Enrollment
100
Registered
2012-10-05
Start date
2012-07-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain of iud insertion. Presence of (intrauterine) contraceptive device

Interventions

Intervention 1: In the first group, seven minutes before insertion of the IUD, 5 g EMLA cream placed on the cervix area with swab cotten. Intervention 2: In the second group, seven minutes before inse
Treatment - Drugs
In the first group, seven minutes before insertion of the IUD, 5 g EMLA cream placed on the cervix area with swab cotten.
In the second group, seven minutes before insertion of the IUD 5 g placebo cream placed on the cervix area with swab cotten.

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: Women aged 35-20 year? Visit during menstruation (days 5-1 cycles)? Do not use pain medication (acetaminophen, ibuprofen, mefenamic acid) 6 hours before visiting? No contraindication for IUD insertion exclusion criteria: Sensitivity EMLA cream (Genesis symptoms of itching, burning, swelling in the area of ??the cervix)? uterine size less than 6 cm and 9 cm? Cervical stenosis

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain IUD insertion. Timepoint: after application of Speculum, tenaculum, hysterometer, insertion IUD and instrument removal. Method of measurement: visual analog scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamira Tavakolian

Fatemiye Hospital.

samira.tavakolian@gmail.com+98 81 1827 3862

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026